Clinical trial
"The Evaluation of Stimulant Withdrawal"
NCT00442923 · Aaron J. Janowsky, Other · Withdrawn
Key facts
| NCT number | NCT00442923 |
|---|---|
| Title | "The Evaluation of Stimulant Withdrawal" |
| Official title | Scientific Component IV: Pharmacotherapy to Prevent Methamphetamine Relapse |
| Acronym | MARC |
| Lead sponsor | Aaron J. Janowsky, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anxiety, Relapse, Substance Addiction |
| Intervention type | Drug |
| Interventions | Coreg |
| Enrollment | 0 |
| Start date | Jul 1, 2007 |
| Primary completion | Jun 30, 2010 |
| Completion | Jun 30, 2011 |
| First posted | Mar 5, 2007 |
| Last update posted | Jan 31, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: